ESSA Pharma Inc
NASDAQ:EPIX
ESSA Pharma Inc
Capital Expenditures
ESSA Pharma Inc
Capital Expenditures Peer Comparison
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ESSA Pharma Inc
NASDAQ:EPIX
|
Capital Expenditures
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Zymeworks Inc
NYSE:ZYME
|
Capital Expenditures
-$4.1m
|
CAGR 3-Years
14%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Capital Expenditures
-$1.9m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Capital Expenditures
-$3.9m
|
CAGR 3-Years
-51%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Capital Expenditures
-$718k
|
CAGR 3-Years
54%
|
CAGR 5-Years
-55%
|
CAGR 10-Years
-21%
|
|
Sunshine Biopharma Inc
OTC:SBFM
|
Capital Expenditures
-$788.1k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-109%
|
CAGR 10-Years
N/A
|